1. The past time-series ILI occurrences over the 5 weeks showed a fluctuating but clear upward trend, with values ['13067', '11626', '11715', '13526', '15614']. Beginning with a decline from 13067 (Week 30, 2022) to 11626 (Week 31, 2022), subsequent weeks saw a recovery and overall escalation, culminating in 15614 (Week 34, 2022), the highest in the observed period. This pattern indicates a gradual intensification of ILI activity by the end of the 5-week span.

2. A strong correlation exists between past time-series ILI occurrences and future ILI occurrences after 5 weeks. The notable rise in Weeks 33 and 34, 2022, serves as a precursor to the future surge of 17337 (Week 39, 2022). This consistent upward trajectory in the latter weeks of the past time-series reflects a momentum in ILI activity that translates into the marked increase observed after 5 weeks.

3. Several specific factors in the summarized CDC reports correlate with the future increase in ILI occurrences:
   - Outpatient visits for ILI displayed slight but consistent growth, increasing from 1.5% (Week 31, 2022) to 1.8% (Week 34, 2022), with the highest rates observed in children aged 0-4 years (rising from 6.1% in Week 31 to 7.0% in Week 34). This indicates rising respiratory illness activity contributing to the future trend.
   - The proportion of deaths attributed to pneumonia, influenza, or COVID-19 (PIC) remained elevated, regularly exceeding the epidemic threshold of 5.5% across all weeks (e.g., 10.0% in Week 33, 2022, to 9.2% in Week 34, 2022). This steady PIC mortality suggests heightened respiratory illness severity, aligning with the future ILI increase.
   - Influenza-related hospitalizations were persistently recorded over the weeks, showing sustained high levels (e.g., 477 in Week 33, 2022, to 486 in Week 34, 2022). This consistency in hospitalizations reflects ongoing respiratory illness pressure contributing to higher future ILI activity levels.

4. In summary, the reported future ILI occurrences of 17337 (Week 39, 2022) are attributable to the clear upward trend in ILI occurrences by the end of Week 34, 2022, the rising outpatient ILI visit percentages, sustained high PIC mortality surpassing epidemic thresholds, and elevated influenza-related hospitalizations. Collectively, these elements underscore a growing burden of respiratory illness that aligns with the observed future rise.